The IC50 of acacetin against acetylcholinesterase was 50.33 ± 0.87 μg/mL, which showed a significant inhibitory effect on acetylcholinesterase activity, which may hold promise for Alzheimer’s disease treatment [49]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.